Pharming Group N.V. PHGUF
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -65.10% | 64.58% | 86.36% | 829.98% | 485.39% |
| Total Depreciation and Amortization | 5.63% | 20.68% | 27.09% | -0.62% | 1,022.18% |
| Total Amortization of Deferred Charges | -- | -- | 4.81% | -- | -- |
| Total Other Non-Cash Items | -57.91% | -67.09% | -73.74% | 914.41% | 490.89% |
| Change in Net Operating Assets | -253.47% | -68.64% | 90.33% | 101.24% | 44.73% |
| Cash from Operations | -182.24% | 741.38% | 14.75% | 228.74% | 188.82% |
| Capital Expenditure | 35.16% | 15.60% | -106.92% | 80.87% | 40.19% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -100.00% | -225.31% | 102.32% | -105.92% | -53.34% |
| Cash from Investing | -100.49% | -974.63% | 99.54% | -108.02% | -53.41% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 13.79% | -1,714.69% | 9.76% | -11.72% | 99.21% |
| Issuance of Common Stock | 16.63% | 1,509.13% | 150.67% | 57,626.09% | -59.43% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -0.37% | 98.00% | -2.19% | -960.38% | -377.66% |
| Cash from Financing | 11.28% | -37.25% | 147.10% | 793.16% | 90.26% |
| Foreign Exchange rate Adjustments | -95.18% | -146.02% | 140.43% | -254.47% | 1,489.76% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 230.96% | -1,904.74% | 326.22% | 197.92% | 773.64% |